FREQUENCY OF HEPATITIS B AND C SEROPOSITIVITY AMONGST PATIENTS UNDERGOING HEMODIALYSIS

I KHAN; S RASHID; S GHUMRO; TU HAQ; A KOUSAR; H ZEB; A ALI; S ALI

doi:10.54112/bcsrj.v2024i1.978

Authors

I KHAN Department of Medicine, Hayatabad Medical Complex Peshawar, Pakistan
S RASHID Institute of Microbiology, University of Veterinary and Animal Sciences (UVAS), Pakistan
S GHUMRO Department of Zoology, Shah Abdul Latif University Khairpur Mir's Sindh, Pakistan
TU HAQ Abbottabad International Medical Institute Abbottabad, Pakistan
A KOUSAR Sahara Medical College Muridke Road, Narowal, Punjab, Pakistan
H ZEB Medical lab sciences (MLS), Iqra National University Peshawar, Pakistan
A ALI BSN, Riphah International University Islamabad, Pakistan
S ALI Centre for Biotechnology and Microbiology (CBM) University of Swat, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.978

Keywords:

Hemodialysis, Seropositivity, HVC, HBV

Abstract

Hepatitis is caused by many viruses, but Hepatitis B and C viruses are the most harmful, showing a unique and noteworthy correlation between kidney disorders and hemodialysis in individuals. Objective: This study aimed to determine the frequency of hepatitis B and C seropositivity amongst hemodialysis individuals. Methods: This cross-sectional study was conducted at the Department of Medicine, Hayatabad Medical Complex Peshawar, after obtaining permission from the ethical board of the institute. The study duration was six months from August 2023 to January 2024. Individuals who were going to perform hemodialysis in the hospital during the study period were enrolled. Sixty-four chronic kidney disease patients were tested for anti-HBsAg and anti-HCV antibodies who visited our hospital for dialysis. All samples were tested for HBs antigen and anti-HCV antibodies using a more sensitive chemiluminescence assay (Vitros, Orthoclinical Technologies). Microsoft Excel was used for data entry, analysis, and interpretation. Results: A total of 64 participants who were going for hemodialysis were examined for seropositivity of hepatitis B and C viruses. The anti-HCV antibody was positive in 21 (32.8.0%) and 9 (14.0%) individuals who were positive for hepatitis B surface antigens. A significant portion of the individuals, 28 (43.75%), had dialysis of less than 50 times while 18 (28.1%) patients had dialysis of 50-100 times. On the other hand, the majority of the patients who tested positive for HCV (73.8%) and HBV (56.3%) also got HD 50 to 100 times. For HBV-infected individuals, the average dialysis stay was 27 months, but for HCV-infected ones, it took 30 months. For both HBV and HCV infections, the length of Hemodialysis revealed a vital risk factor (P < 0.05). Conclusion: It was concluded from the current study that the frequency of hepatitis B seropositivity was 14.0%, while that of hepatitis C was 32.8.0% among participants undergoing dialysis. Viral hepatitis is a severe health risk for hemodialysis patients, especially in underdeveloped nations.

Downloads

Download data is not yet available.

References

Kosaraju K, Faujdar SS, Singh A, Prabhu R. Hepatitis viruses in heamodialysis patients: an added insult to injury? Hepatitis research and treatment. 2013;2013(1):860514.

Alkhan A. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among hemodialysis patients. General Med. 2015;3(1):1-5.

Etik DO, Ocal S, Boyacioglu AS. Hepatitis C infection in hemodialysis patients: A review. World journal of hepatology. 2015;7(6):885.

Deray G, Buti M, Gane E, Jia J-D, Chan HLY, Craxi A, et al. Hepatitis B virus infection and the kidney: renal abnormalities in HBV patients, antiviral drugs handling, and specific follow‐up. Advances in Hepatology. 2015;2015(1):596829.

Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC infectious diseases. 2012;12:1-8.

Alavian SM, BAGHERI‐LANKARANI K, MAHDAVI‐MAZDEH M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodialysis international. 2008;12(3):378-82.

Rahman AM. Hepatitis B and Hepatitis C Virus infection in haemodialysis patients. Journal of Armed Forces Medical College, Bangladesh. 2014;10(2):66-70.

Salvatierra K, Florez H. Prevalence of hepatitis B and C infections in hemodialysis patients. F1000Research. 2016;5:1910.

Ghorbani NR, Djalalinia S, Modirian M, Abdar ZE, Mansourian M, Gorabi AM, et al. Prevalence of hepatitis C infection in Iranian hemodialysis patients: an updated systematic review and meta-analysis. Journal of Research in Medical Sciences. 2017;22(1):123.

Tarif N, Riaz MM, Sabir O, Akhter R, Rafique K, Rizvi N. Prevalence of Hepatitis B core antibodies with negative Hepatitis B surface antigen in dialysis and chronic kidney disease patients. Saudi Journal of Kidney Diseases and Transplantation. 2017;28(4):869-73.

Anwar K, Imran M, Shahzad F, Noreen M, Atif M, Ahmad F. Prevalence of Hepatitis B and Hepatitis C infection among patients undergoing dialysis. J Hum Virol Retrovirol. 2016;3(3):00094.

Shafi ST, Hassan MZ, Saleem M, Anjum R, Abdullah W, Shafi T. Frequency of Hepatitis C in hospitalized patients with chronic kidney disease. Pakistan journal of medical sciences. 2017;33(1):18.

Malhotra R, Soin D, Grover P, Galhotra S, Khutan H, Kaur N. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India. Journal of natural science, biology, and medicine. 2016;7(1):72.

Adane T, Getawa S. The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis. PloS one. 2021;16(6):e0251570.

Bhaumik P, Debnath K. Prevalence of hepatitis B and C among haemodialysis patients of Tripura, India. Euroasian J Hepato-Gastroenterol. 2012;2(1):10-3.

Tajbakhsh R. Prevalence of hepatitis C and B virus infections among hemodialysis patients in Karaj, Iran. Saudi Journal of Kidney Diseases and Transplantation. 2015;26(4):792-6.

Badareen KZ. Prevalence of hepatitis B and C viruses among hemodialysis patients in Southern West Bank, Palestine. International Journal of Research in Medical Sciences. 2016;4(5):1649.

Engle RE, Bukh J, Alter HJ, Emerson SU, Trenbeath JL, Nguyen HT, et al. Transfusion‐associated hepatitis before the screening of blood for hepatitis risk factors. Transfusion. 2014;54(11):2833-41.

Prakash S, Jain A, Sankhwar S, Usman K, Prasad N, Saha D, et al. Prevalence of hepatitis B & C viruses among patients on hemodialysis in Lucknow, Uttar Pradesh. Clinical Epidemiology and Global Health. 2014;2(1):19-23.

Mittal G, Gupta P, Thakuria B, Mukhiya GK, Mittal M. Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. Journal of Clinical and Experimental Hepatology. 2013;3(1):24-8.